Daré Bioscience CEO Sabrina Johnson thought she had a 6-month task to reach fundraising goals for her company, but it ended up taking two years. She says women’s reproductive health companies often have to look for alternative means of financing in the current climate.

Daré Bioscience CEO Sabrina Johnson thought she had a 6-month task to reach fundraising goals for her company, but it ended up taking two years. She says women’s reproductive health companies often have to look for alternative means of financing in the current climate. Photo by Jamie Scott Lytle.

— In the field of women’s reproductive health, it can be very difficult to get the startup capital a company needs to get from concept to market...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129